Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna van Rhenen

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Blood|December 3, 2014
Rapidly progressive neurological deterioration without magnetic resonance imaging abnormalities: intravascular lymphomaAnna van Rhenen, Niels W C J van de Donk
Current Hematologic Malignancy Reports|April 29, 2010
New approaches for the detection of minimal residual disease in acute myeloid leukemiaAnna van Rhenen, Bijan Moshaver, Gert J Ossenkoppele, et al.
Leukemia|October 10, 2025
Heart failure in patients with acute myeloid leukemia (AML) treated with anthracycline agents during remission induction therapy: a systematic review and meta-analysisJesse Geels, Anna van Rhenen, Patrycja Gradowska, et al.
Hematology. American Society of Hematology. Education Program|December 5, 2025
Posttransplant cells for the win? DLI and adoptive cell therapy to eradicate MRDPleun Schonewille, Anna van Rhenen, Renske Mt Ten Ham, et al.
Journal of the American College of Cardiology|April 8, 2026
Cardiovascular Disease Risk in Adults With Hematological Malignancies: A Population-Based Cohort Study Using Linked DatabasesJesse Geels, Anna van Rhenen, Clara Gomes, et al.
Rheumatology (Oxford, England)|February 13, 2019
Second autologous haematopoietic stem cell transplantation in systemic sclerosis-a case reportFemke C C van Rhijn-Brouwer, Julia Spierings, Anna van Rhenen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2009
Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AMLMonique Terwijn, Nicole Feller, Anna van Rhenen, et al.
Journal of Scleroderma and Related Disorders|September 25, 2023
Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantationYu-Hsiang Chiu, Anouk Drijver, Rick Admiraal, et al.
Hemasphere|June 7, 2021
Allogeneic Stem Cell Transplantation Platforms With Ex Vivo and In Vivo Immune Manipulations: Count and AdjustMoniek de Witte, Laura G M Daenen, Lotte van der Wagen, et al.
Bone Marrow Transplantation|September 25, 2025
Pure white cell aplasia following allogeneic hematopoietic stem cell transplantationLaura A Michielsen, Moniek A de Witte, Laura G M Daenen, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Blood|December 3, 2014
Rapidly progressive neurological deterioration without magnetic resonance imaging abnormalities: intravascular lymphomaAnna van Rhenen, Niels W C J van de Donk
Current Hematologic Malignancy Reports|April 29, 2010
New approaches for the detection of minimal residual disease in acute myeloid leukemiaAnna van Rhenen, Bijan Moshaver, Gert J Ossenkoppele, et al.
Leukemia|October 10, 2025
Heart failure in patients with acute myeloid leukemia (AML) treated with anthracycline agents during remission induction therapy: a systematic review and meta-analysisJesse Geels, Anna van Rhenen, Patrycja Gradowska, et al.
Hematology. American Society of Hematology. Education Program|December 5, 2025
Posttransplant cells for the win? DLI and adoptive cell therapy to eradicate MRDPleun Schonewille, Anna van Rhenen, Renske Mt Ten Ham, et al.
Journal of the American College of Cardiology|April 8, 2026
Cardiovascular Disease Risk in Adults With Hematological Malignancies: A Population-Based Cohort Study Using Linked DatabasesJesse Geels, Anna van Rhenen, Clara Gomes, et al.
Rheumatology (Oxford, England)|February 13, 2019
Second autologous haematopoietic stem cell transplantation in systemic sclerosis-a case reportFemke C C van Rhijn-Brouwer, Julia Spierings, Anna van Rhenen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2009
Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AMLMonique Terwijn, Nicole Feller, Anna van Rhenen, et al.
Journal of Scleroderma and Related Disorders|September 25, 2023
Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantationYu-Hsiang Chiu, Anouk Drijver, Rick Admiraal, et al.
Hemasphere|June 7, 2021
Allogeneic Stem Cell Transplantation Platforms With Ex Vivo and In Vivo Immune Manipulations: Count and AdjustMoniek de Witte, Laura G M Daenen, Lotte van der Wagen, et al.
Bone Marrow Transplantation|September 25, 2025
Pure white cell aplasia following allogeneic hematopoietic stem cell transplantationLaura A Michielsen, Moniek A de Witte, Laura G M Daenen, et al.
Pageof 4